Literature DB >> 8434362

Outbreak of Moraxella catarrhalis in a respiratory unit.

S J Richards1, A P Greening, M C Enright, M G Morgan, H McKenzie.   

Abstract

The clinical and epidemiological features of an outbreak of nosocomial Moraxella catarrhalis infection in a respiratory unit are described. Six isolates from five patients were shown to be indistinguishable by immunoblotting and restriction endonuclease analysis and different from 11 other, unrelated clinical strains.

Entities:  

Mesh:

Year:  1993        PMID: 8434362      PMCID: PMC464259          DOI: 10.1136/thx.48.1.91

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  3 in total

1.  Increase in bronchopulmonary infection due to branhamella catarrhalis.

Authors:  D T McLeod; F Ahmad; S Capewell; M J Croughan; M A Calder; A Seaton
Journal:  Br Med J (Clin Res Ed)       Date:  1986-04-26

2.  A nosocomial outbreak of Branhamella catarrhalis confirmed by restriction endonuclease analysis.

Authors:  T F Patterson; J E Patterson; B L Masecar; G E Barden; W J Hierholzer; M J Zervos
Journal:  J Infect Dis       Date:  1988-05       Impact factor: 5.226

Review 3.  Branhamella catarrhalis respiratory infections.

Authors:  H Hager; A Verghese; S Alvarez; S L Berk
Journal:  Rev Infect Dis       Date:  1987 Nov-Dec
  3 in total
  15 in total

1.  Gram-negative Diplococcal Respiratory Infections.

Authors:  Nargis Naheed; Maqsood Alam; Larry I. Lutwick
Journal:  Curr Infect Dis Rep       Date:  2003-06       Impact factor: 3.725

2.  Quantitative detection of Moraxella catarrhalis in nasopharyngeal secretions by real-time PCR.

Authors:  Oliver Greiner; Philip J R Day; Martin Altwegg; David Nadal
Journal:  J Clin Microbiol       Date:  2003-04       Impact factor: 5.948

3.  Pulmonary thin-section CT findings in acute Moraxella catarrhalis pulmonary infection.

Authors:  F Okada; Y Ando; T Nakayama; S Tanoue; R Ishii; A Ono; M Watanabe; H Takaki; T Maeda; H Mori
Journal:  Br J Radiol       Date:  2010-12-01       Impact factor: 3.039

4.  Assessment of complement-mediated killing of Moraxella (Branhamella) catarrhalis isolates by a simple method.

Authors:  C M Verduin; C Hol; E Van Dijke; J A Faber; M Jansze; J Verhoef; H Van Dijk
Journal:  Clin Diagn Lab Immunol       Date:  1995-05

Review 5.  Sleep studies of respiratory function and home respiratory support.

Authors:  A K Simonds
Journal:  BMJ       Date:  1994-07-02

Review 6.  Bacterial infection in chronic obstructive pulmonary disease in 2000: a state-of-the-art review.

Authors:  S Sethi; T F Murphy
Journal:  Clin Microbiol Rev       Date:  2001-04       Impact factor: 26.132

Review 7.  Moraxella catarrhalis: from emerging to established pathogen.

Authors:  Cees M Verduin; Cees Hol; André Fleer; Hans van Dijk; Alex van Belkum
Journal:  Clin Microbiol Rev       Date:  2002-01       Impact factor: 26.132

8.  Lipooligosaccharide P(k) (Galalpha1-4Galbeta1-4Glc) epitope of moraxella catarrhalis is a factor in resistance to bactericidal activity mediated by normal human serum.

Authors:  A Zaleski; N K Scheffler; P Densen; F K Lee; A A Campagnari; B W Gibson; M A Apicella
Journal:  Infect Immun       Date:  2000-09       Impact factor: 3.441

Review 9.  Moraxella catarrhalis: clinical significance, antimicrobial susceptibility and BRO beta-lactamases.

Authors:  K McGregor; B J Chang; B J Mee; T V Riley
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-04       Impact factor: 3.267

10.  The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis.

Authors:  Thierry Wirth; Giovanna Morelli; Barica Kusecek; Alex van Belkum; Cindy van der Schee; Axel Meyer; Mark Achtman
Journal:  Genome Res       Date:  2007-09-25       Impact factor: 9.043

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.